Diagnostic and prognostic factors in patients with prostate cancer: a systematic review protocol

被引：3

作者：

Beyer, Katharina ^{[1
]}

Moris, Lisa ^{[2
]}

Lardas, Michael ^{[3
]}

Haire, Anna ^{[1
]}

Barletta, Francesco ^{[4
]}

Scuderi, Simone ^{[4
]}

Vradi, Eleni ^{[5
]}

Gandaglia, Giorgio ^{[4
]}

Omar, Muhammad Imran ^{[6
]}

MacLennan, Steven ^{[6
]}

Zong, Jihong ^{[7
]}

Farahmand, Bahman ^{[8
]}

Maclennan, Sara J. ^{[6
]}

Devecseri, Zsuzsanna ^{[9
]}

Asiimwe, Alex ^{[5
]}

Collette, Laurence ^{[10
]}

Bjartell, Anders ^{[11
]}

Ndow, James ^{[12
]}

Briganti, Alberto ^{[4
,13
,14
]}

Van Hemelrijck, Mieke ^{[1
]}

机构：

[1] Kings Coll London, Translat Oncol & Urol Res Tour, London, England

[2] Katholieke Univ Leuven, Dept Urol, Univ Hosp Leuven, Leuven, Flanders, Belgium

[3] Metropolitan Hosp Athens, Dept Urol, Athens, Attike, Greece

[4] IRCCS Osped San Raffaele, Div Oncol, Unit Urol, URI, Milan, Lombardia, Italy

[5] Bayer Pharma AG, Med Affairs & PV, Berlin, Germany

[6] Univ Aberdeen, Acad Urol Unit, Hlth Serv Res Unit, Aberdeen, Scotland

[7] Bayer US, Epidemiol, Whippany, NJ USA

[8] Bayer AG, Global Epidemiol, Stockholm, Sweden

[9] Sanofi SA, Paris, Ile De France, France

[10] EORTC, Brussels, Belgium

[11] Skane Univ Hosp, Malmo, Sweden

[12] European Assoc Urol, Guidelines Off, Arnhem, Netherlands

[13] Univ Vita Salute San Raffaele, Urol Res Inst, RCCS San Raffaele Sci Inst, Dept Urol, Milan, Italy

[14] Univ Vita Salute San Raffaele, Urol Res Inst, RCCS San Raffaele Sci Inst, Div Expt Oncol, Milan, Italy

来源：

BMJ OPEN | 2021年 / 11卷 / 02期

基金：

欧盟地平线“2020”;

关键词：

prostate disease; oncology; urological tumours; BIAS; RISK; TOOL; APPLICABILITY; PROBAST;

D O I：

10.1136/bmjopen-2020-040531

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Introduction As part of the PIONEER (Prostate Cancer Diagnosis and Treatment Enhancement Through the Power of Big Data in Europe) Consortium, we will explore which diagnostic and prognostic factors (DPFs) are currently being researched to previously defined clinical and patient-reported outcomes for prostate cancer (PCa). Methods and analysis This research project will follow the following four steps: (1) a broad systematic literature review of DPFs for all stages of PCa, covering evidence from 2014 onwards; (2) discussion of systematic review findings by a multidisciplinary expert panel; (3) risk of bias assessment and applicability with Prediction model Risk Of Bias Assessment Tool criteria, Quality Assessment of Diagnostic Accuracy Studies (QUADAS-2) and the Quality In Prognosis Studies tool (QUIPS) and (4) additional quantitative assessments if required. Ethics and dissemination We aim to develop an online tool to present the DPFs identified in this research and make them available across all stakeholders. There are no ethical implications.

引用

页数：5

共 24 条

[1]

Arksey H., 2005, Int J Soc Res Methodol, V8, P19, DOI [DOI 10.1080/1364557032000119616, 10.1080/1364557032000119616]

[2]

BEYER K, 2019, ANN M EUR ASS UR 15

[3]

Beyer KML, 2019, 11 EUR MULT C UR CAN

[4]

Beyer KMS, 2019, PIONEERS UPDATE INTE

[5]

Beyer KMS, 2019, ANN M EUR ASS UR

[6]

Beyer KMS, 2020, ANN M EUR ASS UR AMS

[7] The percentage of prostate-specific antigen (PSA) isoform [-2]proPSA and the Prostate Health Index improve the diagnostic accuracy for clinically relevant prostate cancer at initial and repeat biopsy compared with total PSA and percentage free PSA in men aged ≤65 years [J].

Boegemann, Martin ;

Stephan, Carsten ;

Cammann, Henning ;

Vincendeau, Sebastien ;

Houlgatte, Alain ;

Jung, Klaus ;

Blanchet, Jean-Sebastien ;

Semjonow, Axel .

BJU INTERNATIONAL, 2016, 117 (01) :72-79

[8]

Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI [10.3322/caac.21492, 10.3322/caac.21609]

[9] Predicting High-Grade Cancer at Ten-Core Prostate Biopsy Using Four Kallikrein Markers Measured in Blood in the ProtecT Study [J].

Bryant, Richard J. ;

Sjoberg, Daniel D. ;

Vickers, Andrew J. ;

Robinson, Mary C. ;

Kumar, Rajeev ;

Marsden, Luke ;

Davis, Michael ;

Scardino, Peter T. ;

Donovan, Jenny ;

Neal, David E. ;

Lilja, Hans ;

Hamdy, Freddie C. .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2015, 107 (07)

[10] Diagnostic, Predictive, Prognostic, and Therapeutic Molecular Biomarkers in Third Millennium: A Breakthrough in Gastric Cancer [J].

Carlomagno, Nicola ;

Incollingo, Paola ;

Tammaro, Vincenzo ;

Peluso, Gaia ;

Rupealta, Niccolo ;

Chiacchio, Gaetano ;

Sotelo, Maria Laura Sandoval ;

Minieri, Gianluca ;

Pisani, Antonio ;

Riccio, Eleonora ;

Sabbatini, Massimo ;

Bracale, Umberto Marcello ;

Calogero, Armando ;

Dodaro, Concetta Anna ;

Santangelo, Michele .

BIOMED RESEARCH INTERNATIONAL, 2017, 2017

← 1 2 3 →